A single-arm, open-label, U.S. expanded access study of vemurafenib in patients with metastatic melanoma.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Lynn Mara Schuchter, Lawrence E. Flaherty, Omid Hamid, Gerald P. Linette, Sigrun Hallmeyer, Rene Gonzalez, Charles Lance Cowey, Anna C. Pavlick, Fred J. Kudrik, David H. Lawson, Kim Allyson Margolin, Antoni Ribas, David F. McDermott, James L. Khatcheressian, Keith T. Flaherty, Bann-Mo Day, Rolf Gerhard Linke, John D. Hainsworth
Institutions: University of Pennsylvania, The Barbara Ann Karmanos Cancer Institute, Angeles Clinic and Research Institute, Washington University in St. Louis, Oncology Specialists, NYU Langone Health, South Carolina Oncology Associates, Emory University, Winship Cancer Institute, Seattle Cancer Care Alliance, University of California, Los Angeles, Beth Israel Deaconess Medical Center, Virginia Cancer Institute, Massachusetts General Hospital, Genentech, Sarah Cannon
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2509176979